Search Results - "Warkentin, P"

Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation by Fox, Ira J, Chowdhury, Jayanta Roy, Chowdhury, Namita Roy, Kaufman, Stuart S, Goertzen, Timothy C, Warkentin, Phyllis I, Dorko, Kenneth, Sauter, Bernhard V, Strom, Stephen C

“…Crigler–Najjar syndrome type I is a recessively inherited disorder characterized by severe unconjugated hyperbilirubinemia beginning at birth. The syndrome…”
Get full text

Alternative approaches in the closed system manufacturing for dendritic cell vaccines by Dafferner, A.J, Britton, H. c, Warkentin, P, Talmadge, J

Get full text

Common citations during fact inspections - comparison of third and fourth editions of the cellular therapy standards by Schwartz, J, Keever-Taylor, C, Gastineau, D, Warkentin, P, Wacker, K

Get full text

Cryopreservation of adenovirus-transfected dendritic cells (DCs) for clinical use by Gülen, D., Maas, S., Julius, H., Warkentin, P., Britton, H., Younos, I., Senesac, J., Pirruccello, Samuel M., Talmadge, J.E.

“…In this study, we examined the effects of cryoprotectant, freezing and thawing, and adenovirus (Adv) transduction on the viability, transgene expression,…”
Get full text

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies by PAVLETIC, Z. S, JOSHI, S. S, NASRATI, K, ARMITAGE, J. O, KESSINGER, A, BISHOP, M. R, PIRRUCCELLO, S. J, TARANTOLO, S. R, KOLLATH, J, REED, E. C, BIERMAN, P. J, VOSE, J. M, WARKENTIN, P. I, GROSS, T. G

“…Forty-one patients were studied at set times after allogeneic blood stem cell transplantation (alloBSCT) for recovery of lymphocyte numbers and function. Cells…”
Get full text

Outcomes of Treatment of Children and Adolescents With Recurrent Non-Hodgkin’s Lymphoma and Hodgkin’s Disease With Dexamethasone, Etoposide, Cisplatin, Cytarabine, and l-Asparaginase, Maintenance Chemotherapy, and Transplantation: Children’s Cancer Group Study CCG-5912 by KOBRINSKY, Nathan L, SPOSTO, Richard, MEADOWS, Anna T, SHAH, Narayan R, ANDERSON, James R, DELAAT, Cynthia, MORSE, Margaret, WARKENTIN, Phyllis, GILCHRIST, Gerald S, COHEN, Mervyn D, SHINA, Donald

“…To determine the toxicity and response rate in children treated with dexamethasone, etoposide, cisplatin, high-dose cytarabine, and L-asparaginase (DECAL) for…”
Get full text

Terminology and labeling of cellular products: 1. Standards by ASHFORD, P, DISTLER, P, SLAPER-CORTENBACH, I, SZCZEPIORKOWSKI, Z, WARKENTIN, P, GEE, A, LANKESTER, A, LARSSON, S, FELLER, I, LOPER, K, PAMPHILON, D, POSTON, L, RABE, F

“…The International Cellular Therapy Coding and Labeling Advisory Group was established to address the growing need for standardization of terminology and…”
Get full text

The tillage effect in sustaining soil functions by Warkentin, Benno P.

“…This paper examines how alteration of soils by tillage changes the sustainability of soil functions. Soil tillage presents an enigma in thinking about soil…”
Get full text

Terminology and labeling of cellular products-2: Implementation plan by ASHFORD, P, DISTLER, P, SLAPER-CORTENBACH, I, SZCZEPIORKOWSKI, Z, WARKENTIN, P, GEE, A, LANKESTER, A, LARSSON, S, FELLER, I, LOPER, K, PAMPHILON, D, POSTON, L, RABE, F

“…The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the…”
Get full text

Structural FSM traversal by Stoffel, D., Wedler, M., Warkentin, P., Kunz, W.

“…This paper discusses a "structural" technique for traversing the state space of a finite state machine (FSM) and its application to equivalence checking of…”
Get full text

Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs G-CSF mobilized PSC products by AGEITOS, A. G, VARNEY, M. L, BIERMAN, P. J, VOSE, J. M, WARKENTIN, P. I, TALMADGE, J. E

“…This study compares the immune properties of peripheral blood stem cell (PSC) products mobilized with different hematopoietic growth factors (HGFs) as well as…”
Get full text

Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT) by Warkentin, P.I.

“…Voluntary accreditation of cells, tissues, and cellular and tissue-based products intended for human transplantation is an important mechanism for improving…”
Get full text

Diffuse pollution : lessons from soil conservation policies by WARKENTIN, B. P

“…Diffuse pollution of water from various land uses requires a control approach different from the uniform regulations that were successful for point sources…”
Get full text

Selective plasminogen binding: Cysteinyl–lysine–dextran protein interactions by Warkentin, Peter H.

“…The dipeptide, l-cysteine– l-lysine, when coupled to a dextran matrix demonstrates a much higher binding of Glu–plasminogen than dextran alone. Plasminogen…”
Get full text

FAHCT accreditation: common deficiencies during on-site inspections by Warkentin, P.I., Nick, L., Shpall, E.J.

“…The Foundation for the Accreditation of Hematopoietic Cell Therapy (FAHCT) was established in 1996 to develop and implement the inspection and accreditation…”
Get full text

Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cells by Bishop, M R, Jackson, J D, O'Kane-Murphy, B, Schmit-Pokorny, K, Vose, J M, Bierman, P J, Warkentin, P I, Armitage, J O, Garrison, L, Kessinger, A

“…Mobilization of peripheral-blood cells (PBC) with cytokines alone results in rapid hematopoietic recovery and avoids the potential morbidity associated with…”
Get more information

Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor by Bishop, M R, Tarantolo, S R, Jackson, J D, Anderson, J R, Schmit-Pokorny, K, Zacharias, D, Pavletic, Z S, Pirruccello, S J, Vose, J M, Bierman, P J, Warkentin, P I, Armitage, J O, Kessinger, A

“…The optimal dose of granulocyte colony-stimulating factor (G-CSF) for mobilization of allogeneic-blood stem cells (AlloBSC) has yet to be determined. As part…”
Get more information

Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia by Kessinger, A, Smith, D M, Strandjord, S E, Landmark, J D, Dooley, D C, Law, P, Coccia, P F, Warkentin, P I, Weisenburger, D D, Armitage, J O

“…This report describes an allogeneic peripheral blood stem cell transplant in a patient who had received marrow ablative therapy. The patient was an 18-year-old…”
Get more information

Allogeneic bone marrow transplantation for children with acute leukemia : long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation by GORDON, B. G, WARKENTIN, P. I, STRANDJORD, S. E, ABROMOWITCH, M, BAYEVER, E, HARPER, J. L, COCCIA, P. F

“…High-dose therapy and allogeneic matched sibling bone marrow transplantation (BMT) is considered to be the treatment of choice for children with relapsed acute…”
Get full text

National Survey of Neonatal Transfusion Practices. I: Red blood cell therapy by LEVY, G. J, STRAUSS, R. G, WARKENTIN, P. I, PEPKOWITZ, S, MAUER, A. M, HINES, D, HUME, H, SCHLOZ, L, ALBANESE, M. A, BLAZINA, J, WERNER, A, SOTELO-AVILA, C, BARRASSO, C, BLANCHETTE, V

“…Neonatal blood component transfusion practices during 1989 were surveyed via a questionnaire developed by the Pediatric Hemotherapy Committee of the American…”
Get full text